When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

30.9.2024

Matrix Augmented Bone Marrow Stimulation (mBMS) with Hyalofast®

JATROS special report: Dr. Obewegeser about the MBMS method with Hyalofast®

Technical article and infographic on the MBMS method & hyalofast by Dr. Obewegeser, which vividly present the application and benefits of this innovative therapy

In the fifth issue of the journal JATROS Orthopedics & Traumatology Rheumatology, Dr. Obewegeser focuses on the MBMS method with Hyalofast®, which has established itself as the gold standard for cartilage regenerative surgery on the ankle joint and is also remarkably effective on the knee joint.

“The MBMS method is the gold standard for cartilage regenerative surgery on the ankle joint and is also highly effective on the knee joint. The advantages are the cost-effective materials, which only require surgical intervention and can be used at any time.”

Read the full JATROS article

To the Hyalofast® product page

To the Marrow Cellution product page

Für weitere Informationen kontaktieren Sie bitte:

More posts

Interview

Miracell Stammzellentherapie: Regeneration mit körpereigenen Zellen

Dr. Gröbner teilt Praxis-Erfahrungen zur Miracell Stammzellentherapie und regenerativer Orthopädie.
Event

Erfolgreicher Auftakt der Cartilage Joint Labs 2026 im Orthopädischen Spital Speising

Erfolgreicher Auftakt der Cartilage Joint Labs 2026 im Orthopädischen Spital Speising
Product Update

HyaloFast® erhält ab 1. Jänner 2026 eine LKF-Codierung

HyaloFast® erhält ab 2026 eine LKF-Codierung. Die neue Position stärkt den einzeitigen matrix-assistierten Knorpelersatz

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.